Viridian Therapeutics (VRDN) Announces Proposed $150M Share and Warrant Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. FIX
8. BE
9. AXP
10. NDAQ

Go back to Viridian Therapeutics (VRDN) Announces Proposed $150M Share and Warrant Offering

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

September 10, 2024 4:01 PM EDT

WALTHAM, Mass.--(BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that it has commenced an underwritten public offering of $150 million of shares of its common stock and Series B non-voting convertible preferred stock. All of the securities to be sold in the underwritten public offering are being offered by Viridian. In addition, Viridian intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common... More